Dialysis in diabetic patients: Hemodialysis and peritoneal dialysis. Pros and cons

Minerva Urologica e Nefrologica

Volumn 64, Issue 3, 2012, Pages 173-182

  Biesenbach, G ^a   Pohanka, E ^a  

^a KEPLER UNIVERSITY HOSPITAL   (Austria)

Author keywords

Diabetes mellitus; Peritoneal dialysis; Renal dialysis

Indexed keywords

HEMOGLOBIN A1C;

CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTINUOUS CYCLER ASSISTED PERITONEAL DIALYSIS; DIABETES MELLITUS; DIALYSIS; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; PATIENT EDUCATION; PERITONEAL DIALYSIS; REVIEW; TREATMENT OUTCOME;

DIABETES MELLITUS; DIABETIC NEPHROPATHIES; GLUCOSE; HUMANS; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; RENAL DIALYSIS;

EID: 84869213206     PISSN: 03932249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Burkart J.The Future of Peritoneal Dialysis in the United States: Optimizing Its Use CJASN 2009;4 Supplement 1 SI25-SI31.
2. Rocco MV. More frequent hemodialysis: back to the future? Adv Chronic Kidney Dis 2007;14:1-9.
3. Stel VS, van de Luijtgaarden MW, Wanner C, Jager KJ on behalf of the European Renal Registry Investigators. The 2008 ERA-EDTA Registry Annual Report-a précisNDT Plus. 2011;4:1-13.
4. Neil N, Guest S, Wong L, Inglese G, Bhattacharyya S, Gehr T, Walker D et al. The financial implications for Medicare of greater use of peritoneal dialysis. Clin Therap 2009;31:880-8.
5. Rubin HR, Fink NE, Plantinga LC.Sadler JE, Kliger AS, Powe NR. Patient ratings of dialysis care with peritoneal dialysis vs hemodialysis. JAMA 2004;291:697-703. (Pubitemid 38543789)
6. Morrrison M. Metabolic defects of CAPD. Ann Rec Med 1989;40:162-72.
7. Vonesh EF, Snyder JJ, Foley RN, Collins Al. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int 2004;66:2389-401.
8. Saxena R, West C. Peritoneal dialysis: a primary care perspective. J Am Board Fam Med 2006;19:380-9. (Pubitemid 44047007)
9. Shirishrimal K, Hart P, Michota F. Managing diabetes in hemodialysis patients: Observations and recommendations. Clev Clin J Med 2009;76.649-55.
10. Biesenbach G, Raml A, Schmekal B, Eichbauer-Sturm G. Decreased insulin requirement in relation to GFR in nephropathic Type 1 and insulin-.treated Type 2 diabetic patients. Diabet Med 2003;20:642-5. (Pubitemid 36966558)
11. Abe M, Okada K, Soma M. Antidiabetic agents in patients with chronic kidney disease and end-stage renal disease on dialysis: metabolism and clinical practice. Curr Drug Metab 2011;12:57-69.
12. DeLuca HF. Regulation of the vitamin D endocrine system located in the kidney. Contrib Nephrol 1978;13:81-95.
13. Quintanilla A, GE Shambaugh 3d, TP Gibson, Craig R. Glucose metabolism in uremia. Am J Clin Nutr 1980;33:1446-50. (Pubitemid 10013686)
14. Grodstein GP, Blumenkrantz MJ, Kopple JD, Moran JK, Coburn JW. Glucose absorption during continuous ambulatory peritoneal dialysis. Kidney Int 1981;19:564-7. (Pubitemid 11120902)
15. Horton ES, C Johnson, HE Lebovitz. Carbohydrate metabolism in uremia. Ann Int Med 1968;1:63-74.
16. Beardsworth SF, Ahmad R, Terry E, Karim K. Intraperitoneal insulin: a protocol for administration during CAPD and review of published protocols. Dialysis Int 1988;8:145-51.
17. Quellhorst E Peritoneal dialysis: pros and cons of various forms of administration. J Am Soc Nephrol 2002;13(Suppl 1):S92-6.
18. Biesenbach GE. Pohanka dialysis: glycated albumin or HbA(1c) in dialysis patients with diabetes? Nat Rev Nephrol 2011;2;7:490-2.
19. 1c: a 6-year progress report. Clin Chem 2008;54:240-8.
20. Ramirez G, Bercaw BL, Butcher DE, Mathis HL, Brueggemeyer C, Newton A. The role of glucose in hemodialysis: the effects of glucose-free dialysate. Am J Kidney Dis 1986;7:13-20.
21. Fasgupta MK. Management of patients with type 2 diabetes on peritoneal dialysis. Adv Perit Dial 2005;21:120-2.
22. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW et al. for the Hemodialysis (HEMO) Study Group: Effect of dialysis dose and membrane flux in maintenance hemodialysis. New Engl J Med 2002;347:2010-9. (Pubitemid 35461657)
23. Cheung AK, Levin NW, Greene T, Agodoa L, Bailey J, Clark W et al. Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study. J Am Soc Nephrol 2003;14:3251-63. (Pubitemid 37509301)
24. Guo A, Mujais S. Patient and technique survival on peritoneal dialysis in the United States: Evaluation in large incident cohorts. Kidney Int 2003;64:(Suppl 88) S3-S12. (Pubitemid 37452809)
25. Mactier RA, Sprosen TS, Goka R, Williams PF, Lindbergh M, Naik RB et al. Bicarbonate and bicarbonate/ lactate peritoneal dialysis solutions for the treatment of infusion pain. Kidney Int 1998,53:1061-7. (Pubitemid 28155684)
26. Saxena R. Peritoneal dialysis: a viable renal replacement therapy option. Am J Med Sci 2005;330:36-47. (Pubitemid 41003685)
27. Domenici A, Comunian MC, Fazzari L, Sivo F, Dinnella A, Delia Grotta B et al. Incremental peritoneal dialysis favourably compares with hemodialysis bridge to renal transplantation. Int J Nephrol 2011;2011:2042.
28. Saxena R, West C. Peritoneal dialysis: a primary care perspective. J Am Board Fam Med 2006;19:380-9. (Pubitemid 44047007)
29. Bender FH, Bernardini J, Piraino B. Prevention of infectious complications in peritoneal dialysis: best demonstrated practices. Kidney Int 2006;(Suppl 103):S44-S54. (Pubitemid 44684775)
30. Bernardini J, Bender F, Florio T, Sloand J, PalmMontalbano L, Fried L et al. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Neph 2005;16:539-45. (Pubitemid 41725152)
31. Twardowski ZJ, Prowant BF, Nichols WK, Nolph KD, Khanna R. Six-year experience with swan neck catheters. Perit Dial Int 1992;12:384.
32. Crabtree JH, Fishman A. A laparoscopic method for optimal peritoneal dialysis access. Am Surg 2005;71:135-43. (Pubitemid 41725312)
33. Gupta S, Muralidharan S, Gokulnath, Srinivasa A. Epidemiology of culture isolates from peritoneal dialysis peritonitis patients in southern India using an automated blood culture system to culture peritoneal dialysate. Nephrology (Carlton) 2011;16:63-7.
34. Daskupta MK. Management of patients with type 2 diabetes in peritoneal dialysis. Adv Periton Dial 2005;21:120-2.
35. Prakash J, Singh LK, Shreeniwas S, Ghosh B, Singh TB. Non-infectious complications of continuous ambulatory peritoneal dialysis and their impact on technique survivlal. Indian J Nephrol 2011;21:112-5.
36. Anne B, Bakewell AB, Higgins RM, Edmunds ME. Quality of life in peritoneal dialysis patients: decline over time. Pediatr Nephrol 2008;23.695-703.
37. Saxena R. Pathogenesis and treatment of peritoneal membrane failure. Clinical outcomes. Kidney Int 2002;61:239-48.
38. Davenport A. Membrane designs and composition for hemodialysis, hemofiltration and hemodialfiltration: past, present and future. Minerva Urol Nefrol 2010;62:29-40.
39. Gondouin B and CA Hutchison. High cut-off dialysis membranes: current uses and future potential. Adv Chronic Kidney Dis 2011;18:180-7.
40. Ronco C, Brendolan A, Bellomo R. Online monitoring in continuos renal replacement therapie. Kidney Int 1999;56.S8-S14.
41. Dalal P, Sangha H, Chaudhary K. Peritoneal dialysis: is there sufficient evidence to make "PD First" therapy? Int J Nephrol 2011;2011:239515.
42. Hendersons LW. Dialysis in the 21st century. Am J Kidney Dis 1996;28:751-7.
43. Ronco C, Dell'Aquila R, Bonello M, Gloukhoff A, Amerling R, Cruz C et al. Continuous flow peritoneal dialysis: a new double lumen catheter. Int J Artif Organs 2003;26.984-90.
44. Vychytil A. Automated peritoneal dialysis - recent aspects. Wiener Klin Wochenschr 2005;117:98-108. (Pubitemid 43205995)
45. Yung S, Chan TM. Intrinsic cells: mesothelial cells central players in regulating inflammation and resolution. Perit Dial Int 2009;29(Suppl 2):S21-7.
46. Yung S, Chan TM. Glycosaminoglycans and proteoglycans: overlooked entities? Perit Dial Int 2007;27(Suppl 2): 104-9.
47. Vychytil A, Hörl WH. The role of tidal peritoneal dialysis in modern practice: A European perspective. Kidney Int Suppl 2006;103.S96-S103. (Pubitemid 44684783)
48. Chitalia VC, Almeida AF, Rai H, Bapat M, Chitalia KV, Acharya VN et al. Is peritoneal dialysis adequate for hypercatabolic acute rena failure in developing countries? Kidney Int 2002;61:747-57. (Pubitemid 34102619)
49. US Renal Data System: USRDS 2007 Annual Data Report. Atlas of chronic kidney and end-stage renal disease in the united states, Bethesda, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2007.
50. Stark A, Murthy BVR, Molony DA. Survival differences between peritoneal dialysis and hemodialysis among "large" ESRD patients in the United States. Kidney Int 2004;65:2398-408. (Pubitemid 38670026)
51. Fenton SA, Schaubel DE, Desmeules M, Morrison HI, Mao Y, Copleston P et al. Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates. Am J Kid Dis 1997;30:334-42. (Pubitemid 27391500)
52. McDonald SP, Marshall MR, Johnson DW, Polkinghorne KR. Relationship between dialysis modality and mortality. J Am Soc Nephrol 2009;20:155-63.
53. Vonesh EF, JJ Snyder, RN Foley2, Collins AJ. Mortality studies comparing peritoneal dialysis and hemodialysis: What do they tell us? Kidney Int 2006;70:S3-S11. (Pubitemid 44684770)
54. Duong U, Mehrotra R, Molnar MZ, Noori N, Kovesdy CP, Nissenson AR et al. Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus Clin J Am Soc Nephrol 2011;6:1041-8.
55. Mehrotra R, Marsh D, Vonesh E, Peters V, Nissenso A. Patient education and access of ESRD patients to renal replacement therapies beyond in-center hemodialysis. Kidney Int 2005;68:378-90. (Pubitemid 43181398)
56. Yadlapalli NG, Schreiber MJ. Peritoneal dialysis training in US nephrology training programs. J Am Soc Nephrol 2001;12.80.
57. Golper T. Patient education: can it maximize the success of therapy? Neph Dial Transplant 2001;16(Suppl 7):20-4. (Pubitemid 33062118)
58. Cavanaugh KL. Diabetes management issues for patients with chronic kidney disease. Clin Diabetes 2007;25:90-7. (Pubitemid 47173894)